Carcinoid Tumor

• CLINICAL_TRIALS trial_result · 2011-10-12
  Clinical Trial Update: ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid [Phase 1]

  Phase 1 clinical trial of Ultratrace iobenguane I-131 in patients with malignant pheochromocytoma, paraganglioma, or metastatic carcinoid ha…

• CLINICAL_TRIALS trial_result · 2011-06-15
  Clinical Trial Update: Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma [Phase 2]

  Phase 2 clinical trial update of Quarfloxin (CX-3543) in patients with low to intermediate grade neuroendocrine tumors completed.

• CLINICAL_TRIALS trial_result · 2011-06-15
  Clinical Trial Update: 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors [Phase 3]

  This is a Phase 3 clinical trial update evaluating 123I‑MIBG scintigraphy for evaluating patients with suspected neuroendocrine tumors, incl…

• CLINICAL_TRIALS trial_result · 2010-08-04
  Clinical Trial Update: Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor [Phase 1, Phase 2]

  A Phase 1/2 clinical trial update evaluating the safety and tolerability of RAD001 (everolimus) daily in Chinese patients with advanced pulm…

• CLINICAL_TRIALS trial_result · 2010-03-10
  Clinical Trial Update: A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors [Phase 2]

  Phase 2 clinical trial evaluating the safety and efficacy of combining Panzem NCD with Avastin in metastatic carcinoid tumors has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2010-02-25
  Clinical Trial Update: Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features [Phase 1]

  A Phase 1 safety study update evaluating Seneca Valley Virus in patients with solid tumors exhibiting neuroendocrine features.